RecallCheckr

Serious recall: Injury is possible or has been reported. Take action promptly.

Randox Laboratories Ltd. 2023-08-16 Health serious FDA
Health · FDA · Recall #FDA-Z-2362-2023

Randox RX Series Urea Enzymatic Kinetic Assay Ref. Numbers: (1) UR3825 (2) UR3873 … Recall

Issued August 16, 2023 · Randox Laboratories Ltd.

In August 2023, Randox Laboratories Ltd. recalled the Randox RX Series Urea Enzymatic Kinetic Assay Ref. Numbers: (1) UR3825 (2) UR3873 …, a serious health recall reported by the FDA.

Compiled by Maya Ellison, RecallCheckr

What this means for you

Carryover from the Direct LDL-cholesterol assay on the Rx instruments may result in a negative bias, up to -11%, in quality control and patient samples, in urea assays results if the urea assay is run immediately after the Direct LDL-cholesterol assay. This may lead to a delay in reporting results or in falsely decreased urea test results.

What you should do

  1. 1 Stop using Randox RX Series Urea Enzymatic Kinetic Assay Ref. Numbers: (1) UR3825 (2) UR3873 … right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Randox Laboratories Ltd. to arrange your voluntary. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):

Recall details

Brand
Randox Laboratories Ltd.
Category
Health
Recall date
August 16, 2023
Units affected
Not reported
Sold at
US Nationwide distribution in the states of CA, DC, GA, OH, OK, MN, MO, NJ, VA and Puerto Rico.
Recall number
FDA-Z-2362-2023
Made in
Ireland
Issuing agency
FDA

In context

  • Randox Laboratories Ltd. has 5 recalls in our database.
  • We're tracking 3,576 Health recalls in our database.
  • This is the 903rd Health recall we've logged in 2023.
Read the official FDA notice

Related recalls